GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baumer SA (BSP:BALM4) » Definitions » 3-Year EPS without NRI Growth Rate

Baumer (BSP:BALM4) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Baumer 3-Year EPS without NRI Growth Rate?

Baumer's EPS without NRI for the three months ended in Sep. 2023 was R$-0.38.

During the past 12 months, Baumer's average EPS without NRI Growth Rate was -83.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Baumer was 362.10% per year. The lowest was -75.60% per year. And the median was 18.00% per year.


Competitive Comparison of Baumer's 3-Year EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Baumer's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baumer's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baumer's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Baumer's 3-Year EPS without NRI Growth Rate falls into.



Baumer 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Baumer  (BSP:BALM4) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Baumer 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Baumer's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Baumer (BSP:BALM4) Business Description

Traded in Other Exchanges
Address
Avenue Prefeito Antonio Tavares Leite, 181, District Ind. Jose, Marangoni, Mogi Mirim, SP, BRA
Baumer SA develops solutions in hospitals and health industry equipments. It has various segments like Orthopedic Implants, Biomaterials, Sterilization, Infections Control, Surgical Centers, Water Treatment and solid residuals Health Treatment Divisions. The company also provides surgical center solutions, including anesthesia systems, lighting products, surgical tables, and orthopedic solutions consisting of hip and knee prosthesis, shoulder prosthesis, non-conventional orthopedic solutions, intramedullary fixation solutions, external and internal fixations, and biomaterials. In addition, it offers spine solutions, such as fixation system locks, occipitocervial fixation systems, angled cervical cages, and posterior lumbar cages.

Baumer (BSP:BALM4) Headlines

No Headlines